The Impact of Memory Problems on Diabetes Treatment in Germany

Abstract

Since 2008, the Caisse Nationale d'Assurance Maladie des Travailleurs Salariéshas set up a diabetic patient support programme in ten pilot departments in France. In addition to written advice, programme members also have access to telephone support from health education nurses. In 2010, the sophia programme was extended to another nine departments and, at the beginning of 2013, it was generalized to all French departments. The present study evaluated the health economics impact of the programme after a follow-up of 3 years. This analysis follows a preliminary assessment that demonstrated positive results after 1 year. MethOds: The variation of various health care use indicators as well as outpatient and inpatient costs was compared between three cohorts: members of pilot departments, non-members, and a control group of diabetic patients living in departments in which sophia was not available. Results are adjusted for between-group differences observed at the beginning of the programme. Results: Adjusted analysis showed that, after matching for all other characteristics, compliance with recommended examinations improved to a much greater extent among programme members than among control subjects and non-members. Although all health care costs continued to increase in each cohort, outpatient and inpatient expenditure was € 226 lower for programme members than for controls for the period 2009-2011:-€ 54 for outpatient care and-€ 172 for inpatient care. Although the outpatient expenditure of programme members was higher (+€ 40) for outpatient visits and medical procedures, their paramedical expenditure was lower (-€ 89). Hospitalization rates for diabetes were significantly lower among members than among controls. cOnclusiOns: These results confirm the significant impact of the sophia programme on compliance with clinical practice guidelines in diabetology, hospitalization rates, and the 3-year growth of outpatient and inpatient costs. An assessment of the impact of the sophia programme on clinical parameters will be conducted in the near future. PDB106 ConsistenCy of Current tyPe 2 DiaBetes (t2DM) treatMent Patterns in General PraCtiCe Versus the 2013 frenCh has t2DM GuiDelines: a transVersal stuDy BaseD on the frenCh iMs lifelinktM ProsPeCtiVe DiaBetes Cohort

Digital Diabetes Management: A Literature Review of Smart Insulin Pens

“…The overall benefits of smart insulin pens may be particularly useful for certain subpopulations, such as young and elderly individuals with diabetes, and people with additional physical conditions or disabilities that may hinder self-management. 37 Smart insulin pens with connectivity improve communication with healthcare providers through data sharing, resulting in robust transparency; thus, people for whom these devices will likely be beneficial include those starting insulin who present with the potential for hypoglycemia and/or excess weight gain; those for whom hypoglycemia is a recurrent problem or in whom there is hypoglycemia unawareness; those with frequent episodes of uncontrolled diabetes requiring unscheduled visits to healthcare providers; those with glycemic variability that causes psychological distress; those for whom forgetfulness is frequent or in whom deliberate insulin omission is suspected 39 ; those whose numeracy makes dose calculations difficult or who tend to give similar doses for very different meals; children with type 1 diabetes; older insulin-treated individuals living on their own; and women with gestational diabetes requiring insulin. 24 , 40 These benefits may also extend to caregivers of people with diabetes and healthcare workers managing patients with diabetes in the inpatient setting.…”